2-(9,9'-Spirobi[fluoren]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 10g

5-Nitro-1H-indazol-6-ol, 95.0%, 1g

Methyl 4-chloroquinazoline-6-carboxylate, 95.0%, 10g

ETHYL 7-AMINOQUINOLINE-2-CARBOXYLATE, 95.0%, 250mg

H-HoCys-OH, 95+%, 25g

Acétate de sodium trihydraté, min.99%, Ph.Eur., USP, 5 kg, emballage plastique.

(2-Fluoro-6-formylphenyl)boronic acid, 97%, 25g

ETHYL 2-(AZETIDIN-3-YL)ACETATE TFA, 95%, 1g

4-Methoxy-N-methylbenzylamine>98.0%(GC)(T)1g

2-Chloro-4-methylphenol, 95.0%, 10g

4-(3-Bromo-4-fluorophenyl)-3-(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazol-5(4H)-one, 98%, 500mg

(9H-fluoren-9-yl)methyl (R)-3-hydroxypyrrolidine-1-carboxylate, 98%, 5g

4,4,5,5-Tetramethyl-2-(tetrahydro-2H-pyran-4-yl)-1,3,2-dioxaborolane, 95.0%, 5g